K. Panageas
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- BRCA gene mutations in cancer
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Co-authors
- Lisa M. DeAngelis (8 shared papers)Alan Z. Segal (2 shared papers)Douglas M. Weine (1 shared paper)Dean M. Cestari (1 shared paper)Anne S. Reiner (4 shared papers)Maura N. Dickler (5 shared papers)Karen H. Antman (1 shared paper)Alfred I. Neugut (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Neurology (2 papers)Neuro-Oncology (2 papers)Annals of Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
K. Panageas
30 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 95
- Genetics 359
- Internal Medicine 123
- Neurology 476
- Oncology 607
- Pathology and Forensic Medicine 382
Countries citing papers authored by K. Panageas
This map shows the geographic impact of K. Panageas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Panageas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Panageas more than expected).
Fields of papers citing papers by K. Panageas
This network shows the impact of papers produced by K. Panageas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Panageas. The network helps show where K. Panageas may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Panageas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 316 | |
| 2 | 2004 | 269 | |
| 3 | Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. | 2000 | 170 |
| 4 | 1998 | 161 | |
| 5 | 2007 | 133 | |
| 6 | 2011 | 102 | |
| 7 | 2010 | 89 | |
| 8 | 2003 | 75 | |
| 9 | 2011 | 70 | |
| 10 | 2007 | 65 | |
| 11 | 1999 | 43 | |
| 12 | 2004 | 41 | |
| 13 | 2005 | 36 | |
| 14 | 2010 | 30 | |
| 15 | Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. | 2001 | 25 |
| 16 | 2006 | 22 | |
| 17 | 2012 | 20 | |
| 18 | 2010 | 17 | |
| 19 | 2011 | 14 | |
| 20 | 2010 | 10 |
About K. Panageas
K. Panageas is a scholar working on Oncology, Genetics, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Cutaneous Melanoma Detection and Management (3 papers), Brain Metastases and Treatment (3 papers), Breast Lesions and Carcinomas (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Genetics (359 citations), Internal Medicine (123 citations), Neurology (476 citations), Oncology (607 citations) and Pathology and Forensic Medicine (382 citations). K. Panageas has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Lisa M. DeAngelis, Alan Z. Segal, Douglas M. Weine, Dean M. Cestari, Anne S. Reiner, Maura N. Dickler, Karen H. Antman, Alfred I. Neugut, William Whang and Victor R. Grann. Their work appears in journals such as Journal of Clinical Oncology, Neurology, Neuro-Oncology, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.